Is a global rights-based COVID-19 vaccine roll out possible?
Globally, there have been nearly 65 million confirmed cases of COVID-19 and over 1.5 million deaths, according to the WHO. COVID-19 has worsened existing inequalities and disproportionately impacted communities like seniors, frontline healthcare and other essential workers, communities of color, people living in poverty, and those with pre-existing conditions. In addition, countries are approaching the virus in a myriad of ways and to varying degrees of success. As the world looks to vaccines, the coordination of an equitable global vaccine distribution is uncertain.
Who decides which groups receive a vaccine first, and when? How will we successfully manufacture and share it globally? Who pays for it and its delivery?
On December 9, 2020, these questions and more were discussed by our panel of experts, led by Chelsea Clinton, in an event hosted by the Global Health Justice & Governance Program. You can view the recording below, or via PopFam's YouTube channel.
MODERATOR
Chelsea Clinton, DPhil, MPH
Vice Chair, The Clinton Foundation
Adjunct Assistant Professor of Health Policy and Management,
Columbia University Mailman School of Public Health
PANELISTS
Dr. Iain Barton, MB ChB
CEO, Clinton Health Access Initiative
Dr. Precious Lunga, PhD
CEO & Co-Founder, Baobab Circle
Nina Schwalbe, MPH
CEO, Spark Street Advisors
Adjunct Assistant Professor of Population and Family Health,
Columbia University Mailman School of Public Health
Dr. Prashant Yadav, PhD
Senior Fellow, Center for Global Development
Affiliate Professor of Technology and Operations, INSEADÂ
Lecturer, Harvard Medical School
OPENING AND CLOSING REMARKS
Terry McGovern, JD
Professor and Chair of the Heilbrunn Department of Population and Family Health,
Columbia University Mailman School of Public Health
Director, Global Health Justice & Governance Program